Inflammatory Bowel Disease (IBD) is a term used to describe a group of disorders characterized by chronic inflammation of the gastrointestinal tract, with Crohn's Disease (CD) and Ulcerative Colitis (UC) being the most common. While still not fully understood, pathogenesis is believed to be multifactorial - the result of an interplay between genetic susceptibility, immune…
Frontiers in Gastroenterology Template
Write in a clean editor, then format for Frontiers in Gastroenterology in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Frontiers in Gastroenterology format
Frontiers in Gastroenterology is a peer-reviewed journal published by Frontiers, covering Inflammatory Bowel Disease, Gut microbiota and health, Liver Disease Diagnosis and Treatment. Over its lifetime it has published 219 papers, which have received 527 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Gastroenterology. 2023;12(3):45–58.
Formats any DOI in Frontiers in Gastroenterology style. No sign-up. |
| Publishes research in | Inflammatory Bowel Disease Gut microbiota and health Liver Disease Diagnosis and Treatment Microscopic Colitis Gastrointestinal motility and disorders |
| ISSN | 2813-1169 |
| Citation impact (2-yr) | 1.43 |
| h-index | 10 |
| i10-index | 12 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Istituti di Ricovero e Cura a Carattere Scientifico |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Frontiers in Gastroenterology per year
Citation impact of Frontiers in Gastroenterology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Frontiers in Gastroenterology
Akkermansia muciniphila (A. muciniphila) is an anaerobic, Gram negative and mucin-degrading bacterium of the phylum Verrucomicrobia isolated in 2004 from human feces. Although it is a common resident in the human intestinal tract, it has also been detected in other anatomical sites. Genomic studies have revealed that A. muciniphila can be divided into different phylogroups…
This review provides an overview of the current data regarding sex- and gender-specific aspects in patients with inflammatory bowel diseases. A particular focus will be on disease course, medical and surgical treatment strategies, psychosocial differences, and special requirements during pregnancy and family planning. The most significant and clinically meaningful gender differences in IBD relate to…
Background The ideal treatment approach for H. pylori infection has not yet been defined; therefore, the most effective management strategies for adult patients need to be identified to ensure clinical practice is aligned with the best standard of care. Our aim was to perform a review of research studies from the European Registry on H.…
The gut-heart axis is an emerging concept highlighting the crucial link between gut microbiota and cardiovascular diseases (CVDs). Recent studies have demonstrated that gut microbiota is pivotal in regulating host metabolism, inflammation, and immune function, critical drivers of CVD pathophysiology. Despite a strong link between gut microbiota and CVDs, this ecosystem's complexity still needs to…